Skip to content

Comparison of two different vitamin D doses for bone strength protection in nephrotic syndrome

Comparison of two vitamin D dosing regimens for osteoprotection in children with new-onset and infrequently relapsing nephrotic syndrome treated with steroids : a randomized trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/04/005721
Enrollment
90
Registered
2015-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- New-onset,Infrequently relapsing nephrotic syndrome

Interventions

Intervention1: STUDY ARM B Calcium and Vitamin D: Elemental calcium 500mg,Vitamin D 400 iu per day for 6 weeks in infrequently relapsing nephrotic syndrome ,3 months in case of new-onset nephrotic syn

Sponsors

JIPMER Intramural fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria : Children with new- onset and infrequently relapsing nephrotic syndrome receiving steroids, attending pediatric nephrology clinic and pediatric wards, JIPMER

Exclusion criteria

Exclusion criteria: Exclusion criteria : i) Children with history of hypocalcemic seizure, tetany, rickets or fractures. ii) Known cases of renal stones. iii) Children with NS already on calcium and vitamin D supplements. iv) Sexual maturity rating (SMR grade 2, by Tanner staging) and above. v) Frequently relapsing, steroid dependent and steroid resistant NS. vi) Children on cyclosporine therapy, phenytoin, phenobarbitone, methotrexate or requiring any immunosuppressant other than prednisolone. vii) Chronic renal failure or chronic liver disease. viii) Secondary causes of NS (e. g IgA nephropathy, Henoch Schonlein Purpura nephritis ,Lupus nephritis)

Design outcomes

Primary

MeasureTime frame
Bone mineral contentTimepoint: Before and after steroid therapy

Secondary

MeasureTime frame
i)serum 25-hydroxy-cholecalciferol ii)Bone Mineral Density iii)serum calcium, phosphate and alkaline phosphatase iv)serum intact parathormone (iPTH) levels Timepoint: Before and after steroid therapy

Countries

India

Contacts

Public ContactDrSriram krishnamurthy

JIPMER

drsriramkris@gmail.com9442121326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026